Colgate-Palmolive Company (CL) is currently trading at $86.06. Based on 20 Wall Street analysts, the average target price is $98.80, implying a 14.8% upside. The consensus recommendation is BUY.

Over the past 30 days, the feed records 0 target raises and 1 target cut for CL. Over the past 90 days, the feed records 10 target raises and 2 target cuts for CL.

CL

Colgate-Palmolive Company

Consumer StaplesOpinion: buy

Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).

Price (USD)

$86.06

Consensus target price range

Low–high band from analyst PT changes in the last 3 months; median & sample mean vs current price

LowHigh
$87.00$110.00
Current $86.06
Median: $103.00Mean: $100.31Current: $86.06

Recent price target updates (latest 80)

  • Piper SandlerSep 21, 2026

    PT action: Lowers

    $98.00 → $95.00

  • RBC CapitalSep 8, 2026

    PT action: Maintains

    $104.00 → $104.00

  • UBSAug 3, 2026

    PT action: Raises

    $106.00 → $109.00

  • TD CowenAug 3, 2026

    PT action: Raises

    $85.00 → $90.00

  • JP MorganAug 3, 2026

    PT action: Lowers

    $104.00 → $103.00

  • RBC CapitalAug 3, 2026

    PT action: Raises

    $102.00 → $104.00

  • Evercore ISI GroupAug 3, 2026

    PT action: Raises

    $100.00 → $101.00

  • BarclaysJul 21, 2026

    PT action: Raises

    $80.00 → $87.00

  • JP MorganJul 16, 2026

    PT action: Raises

    $96.00 → $104.00

  • UBSJul 16, 2026

    PT action: Raises

    $100.00 → $106.00

  • CitigroupJul 14, 2026

    PT action: Raises

    $105.00 → $110.00

  • Piper SandlerJul 9, 2026

    PT action: Raises

    $92.00 → $96.00

  • Wells FargoJul 8, 2026

    PT action: Raises

    $92.00 → $95.00

  • BernsteinJun 11, 2026

    PT action: Announces

    $0.00 → $96.00

  • BarclaysMay 5, 2026

    PT action: Raises

    $79.00 → $80.00

  • JP MorganMay 4, 2026

    PT action: Raises

    $95.00 → $96.00

  • UBSMay 4, 2026

    PT action: Raises

    $98.00 → $100.00

  • RBC CapitalMay 4, 2026

    PT action: Maintains

    $102.00 → $102.00

  • Morgan StanleyApr 23, 2026

    PT action: Lowers

    $100.00 → $95.00

  • Rothschild & CoApr 21, 2026

    PT action: Raises

    $93.00 → $100.00

Band uses only the revised target (Current column) from firm actions dated within the last 3 months—not the Prior price.

Avg Target

$98.80

Based on 20 analysts

Analyst Recommendations

Buy (13)Hold (8)Sell (0)

Upside

+14.80%

Market Cap

$68.60B

Financial & Investment Metrics

Next Earnings Date
Oct 30, 2026D-34
P/E Ratio (TTM)33.88
Forward P/E20.98
P/B Ratio290.74
Dividend Yield2.46%
Return on Equity (ROE)267.37%
Operating Margin20.97%
Debt to Equity1388.16
Beta (Volatility)0.32
52 Week Range$74.55 - $99.33
LowCurrent: $86.06High

Daily editorial mentioning CL

Stock spotlight

Colgate-Palmolive (CL) Faces 3.2% Upside as Institutional Selling Emerges

Colgate-Palmolive currently sits at 18th in the Consumer Staples sector regarding implied upside, a position that reflects a more cautious street sentiment than some of its more volatile peers. As of the data window ending July 13, 2026, the stock trades at $93.21 against a mean analyst target of $96.20, suggesting a modest 3.2% path forward. While twenty analysts maintain a buy consensus on the name, the narrow gap between current pricing and the mean target indicates that the market has already priced in a significant portion of the expected value for the near term.

Targets and valuation

Analysts have been actively adjusting their expectations for the firm, with recent activity highlighting a tightening of ranges. Piper Sandler moved its target from $92 to $96 on July 9, following a Wells Fargo adjustment that lifted their target from $92 to $95 just a day prior. Bernstein also signaled a $96 target on June 11. Despite these revisions, the valuation remains elevated, with a trailing P/E of 36.13 and a forward P/E of 23.00, suggesting that investors are paying a premium for the firm's stability, which is further evidenced by a low beta of 0.319.

That spread matters because it highlights the market's preference for defensive positioning in the current climate. It is worth observing the internal activity alongside these price targets; while the analyst consensus remains firm, there have been ten instances of meaningful insider selling totaling 277,134 shares, with zero corresponding buys. Investors looking for further context on these shifts can monitor Colgate-Palmolive Company for upcoming earnings data due July 31.

Peer comparison

The discrepancy between Colgate-Palmolive’s 3.2% upside and the broader Consumer Staples sector average of 8.5% is stark. When placed alongside competitors, CL occupies a unique space, often serving as a low-volatility anchor in portfolios. By comparison, names like Constellation Brands (STZ) are currently sporting a significantly higher implied upside of 27.1%. Other peers like Hershey (HSY) and Tyson Foods (TSN) also present higher potential variances, at 22.2% and 21.6% respectively. This ranking suggests that while CL remains a cornerstone of the sector, the current price action is constrained relative to the broader group. The combination of a low-beta profile and a dividend yield of 2.33% implies that market participants are prioritizing capital preservation over aggressive growth, even as analyst targets continue to drift upward in response to recent performance.

Read article →

Insider Sentiment Index (Last 6 Months)

Counts and listings exclude stock awards, gifts, and option exercises—open-market purchases and sales only.

Buy vs Sell (Count)

Insider Buys: 0Insider Sells: 10

Whale Trades (C-Level Large Buys)

No major insider buying detected recently.

Recent Insider Transactions

DateNamePositionTransactionShares
8/24/2026TSOURAPAS PANAGIOTISOfficerSale at price 92.05 per share.10,000
8/6/2026CAHILL JOHN TDirectorSale at price 93.37 per share.4,170
8/5/2026WALLACE NOEL RChief Executive OfficerSale at price 91.92 - 92.52 per share.322,042
5/15/2026MALCOLM GREGORYOfficerSale at price 88.44 per share.2,300
5/7/2026MASSEY SALLYOfficerSale at price 87.41 per share.8,599
2/12/2026TSOURAPAS PANAGIOTISOfficerSale at price 94.61 - 97.81 per share.50,000
2/10/2026HAZLIN JOHNOfficerSale at price 94.25 per share.20,989
2/6/2026MALCOLM GREGORYOfficerSale at price 94.91 per share.12,747
2/5/2026MASSEY SALLYOfficerSale at price 95.03 per share.15,851
2/4/2026DANIELS JENNIFER M.OfficerSale at price 94.34 per share.22,000

Frequently Asked Questions

Q. What is the current target price and upside for CL?

A. The current target price for Colgate-Palmolive Company is $98.80, which implies a 14.8% upside from the current price of $86.06. This is based on the consensus of 20 Wall Street analysts.

Q. What is the current analyst recommendation for CL?

A. Currently, there are 6 Strong Buy, 7 Buy, 8 Hold, 0 Sell, and 0 Strong Sell ratings. The overall consensus is BUY.

Q. Are insiders buying CL stock recently?

A. Over the past 6 months, there have been 0 insider buys and 10 insider sells. Insider selling is more prominent recently.

Other Promising Stocks in Consumer Staples

Data provided by Yahoo Finance. This information is for informational purposes only and does not constitute investment advice. We bear no legal responsibility for any investment decisions made based on this data.

Read full disclaimer →